Cargando…

Identification and Management of Statin-Associated Symptoms in Clinical Practice: Extension of a Clinician Survey to 12 Further Countries

PURPOSE: Statins are the first-choice pharmacological treatment for patients with hypercholesterolemia and at risk for cardiovascular disease; however, a minority of patients experience statin-associated symptoms (SAS) and are considered to have reduced statin tolerance. The objective of this study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosenson, Robert S., Gandra, Shravanthi R., McKendrick, Jan, Dent, Ricardo, Wieffer, Heather, Cheng, Lung-I, Catapano, Alberico L., Oh, Paul, Kees Hovingh, G., Stroes, Erik S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427112/ https://www.ncbi.nlm.nih.gov/pubmed/28466399 http://dx.doi.org/10.1007/s10557-017-6727-0

Ejemplares similares

Testing for minimal residual disease in adults with acute lymphoblastic leukemia in Europe: a clinician survey
por: Pigneux, Arnaud, et al.
Publicado: (2018)

Effect of PCSK9 Inhibition on the Plasma Proteome: A SPIRE SubStudy
por: Kraaijenhof, Jordan M., et al.
Publicado: (2023)

Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
por: Stroes, Erik S., et al.
Publicado: (2015)

Angiopoietin-like 3 inhibition and the liver: less is more?
por: Oostveen, Reindert F., et al.
Publicado: (2023)

Combination therapy in cholesterol reduction: focus on ezetimibe and statins
por: Grigore, Liliana, et al.
Publicado: (2008)

Systematic Review and Network Meta‐Analysis on the Efficacy of Evolocumab and Other Therapies for the Management of Lipid Levels in Hyperlipidemia
por: Toth, Peter P., et al.
Publicado: (2017)

The iterative lipid impact on inflammation in atherosclerosis
por: Kraaijenhof, Jordan M., et al.
Publicado: (2021)

Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy
por: Ballantyne, Christie M, et al.
Publicado: (2019)

Statins in the perioperative period
por: Mohebi, Reza, et al.
Publicado: (2019)

Extending Docker: master the art of making Docker more extensible, composable, and modular by leveraging plugins and other supporting tools
por: McKendrick, Russ
Publicado: (2016)

Statin diabetogenicity: guidance for clinicians
por: Ray, Kausik
Publicado: (2013)

Statin Intolerance: the Clinician’s Perspective
por: Stulc, Tomáš, et al.
Publicado: (2015)

Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract
por: Mach, François, et al.
Publicado: (2018)

Understanding the Patient Perception of Statin Experience: A Qualitative Study
por: Vrablik, Michal, et al.
Publicado: (2019)

Statin non-adherence: clinical consequences and proposed solutions
por: Rosenson, Robert S.
Publicado: (2016)

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease : Consensus Statement of the European Atherosclerosis Society
por: Nordestgaard, Børge G., et al.
Publicado: (2013)

Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction
por: Nurmohamed, Nick S, et al.
Publicado: (2023)

Statins use and the risk of all and subtype hematological malignancies: a meta-analysis of observational studies
por: Pradelli, Danitza, et al.
Publicado: (2015)

Efficacy of alirocumab according to background statin type and dose: pooled analysis of 8 ODYSSEY Phase 3 clinical trials
por: Catapano, Alberico L., et al.
Publicado: (2017)

Assessment of the 1% of Patients with Consistent < 15% Reduction in Low-Density Lipoprotein Cholesterol: Pooled Analysis of 10 Phase 3 ODYSSEY Alirocumab Trials
por: Bays, Harold E., et al.
Publicado: (2018)

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
por: Cuchel, Marina, et al.
Publicado: (2014)

A Retrospective Study to Examine Healthcare Costs Related to Cardiovascular Events in Individuals with Hyperlipidemia
por: Henk, Henry J., et al.
Publicado: (2015)

LDL-C calculated by Friedewald, Martin-Hopkins, or NIH equation 2 versus beta-quantification: pooled alirocumab trials
por: Ginsberg, Henry N., et al.
Publicado: (2021)

Clinicians’ Perspectives on Cure in Adult Patients with Acute Lymphoblastic Leukemia with Minimal Residual Disease: A Delphi Study
por: Gidman, Wendy, et al.
Publicado: (2019)

Prevention of cardiovascular disease in patients with familial hypercholesterolaemia: The role of PCSK9 inhibitors
por: Pećin, Ivan, et al.
Publicado: (2017)

Erratum to: ‘Costs of treating cardiovascular events in Germany: a systematic literature review’
por: Schmid, Tamara, et al.
Publicado: (2016)

Trends in Utilization of Statin Therapy and Contraindicated Statin Use in HIV‐‐Infected Adults Treated With Antiretroviral Therapy From 2007 Through 2015
por: Rosenson, Robert S., et al.
Publicado: (2018)

The Necessity for Yet Further Extension of Clinics
Publicado: (1920)

Medical costs associated with cardiovascular events among high-risk patients with hyperlipidemia
por: Bonafede, Machaon M, et al.
Publicado: (2015)

Shared Decisions: A Qualitative Study on Clinician and Patient Perspectives on Statin Therapy and Statin‐Associated Side Effects
por: Ahmed, Sarah T., et al.
Publicado: (2020)

Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?
por: Goh, Myung Ji, et al.
Publicado: (2022)

Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance
por: Laufs, Ulrich, et al.
Publicado: (2019)

A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations
por: Serban, Corina, et al.
Publicado: (2015)

Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors and statins: an analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration
por: Ference, Brian A, et al.
Publicado: (2018)

Healthcare Utilization and Statin Re‐Initiation Among Medicare Beneficiaries With a History of Myocardial Infarction
por: Booth, John N., et al.
Publicado: (2018)

Treatment patterns with etanercept and adalimumab for psoriatic diseases in a real-world setting
por: Bonafede, Machaon, et al.
Publicado: (2013)

Patient-level costs of major cardiovascular conditions: a review of the international literature
por: Nicholson, Gina, et al.
Publicado: (2016)

Pharmacodynamic effect of bempedoic acid and statin combinations: predictions from a dose–response model
por: Jadhav, Satyawan B, et al.
Publicado: (2021)

Regional Variations in Alirocumab Dosing Patterns in Patients with Heterozygous Familial Hypercholesterolemia During an Open-Label Extension Study
por: Langslet, Gisle, et al.
Publicado: (2020)

Adrenal Function in Females with Low Plasma HDL-C Due to Mutations in ABCA1 and LCAT
por: Bochem, Andrea E., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_sp4gv6v6bpe3loduje6fvia9bi